(Q34590737)

3 August 2017

1 reference

title

Chemotherapeutic dose intensification for treatment of malignant brain tumors: recent developments and future directions (English)

1 reference

3 August 2017

1 reference

1 reference

3

Edward A Neuwelt

1 reference

3 August 2017

2

David Fortin

1 reference

3 August 2017

Dale F Kraemer

1

1 reference

3 August 2017

publication date

1 May 2002

1 reference

Current Neurology and Neuroscience Reports

3 August 2017

published in

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

216-224

1 reference

Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation

3 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11910-002-0080-8

The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery

21 January 2018

1 reference

12 December 2020

Isolation and characterization of human malignant glioma cells from histologically normal brain.

1 reference

12 December 2020

Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice

1 reference

12 December 2020

Meta-analysis in hematology and oncology

1 reference

12 December 2020

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

12 December 2020

First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate

1 reference

12 December 2020

Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.

1 reference

12 December 2020

Convection-enhanced delivery of macromolecules in the brain

1 reference

12 December 2020

Association of total dose intensity of chemotherapy in primary central nervous system lymphoma (human non-acquired immunodeficiency syndrome) and survival.

1 reference

12 December 2020

High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence.

1 reference

12 December 2020

A model system for in vivo gene transfer into the central nervous system using an adenoviral vector

1 reference

12 December 2020

Treatment of intracranial nongerminomatous germ-cell tumor by high-dose chemotherapy and autologous stem-cell rescue

1 reference

12 December 2020

1 reference

12 December 2020

Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy

1 reference

12 December 2020

Intracerebral clysis in a rat glioma model.

1 reference

12 December 2020

Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapy

1 reference

12 December 2020

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means

1 reference

12 December 2020

Cytochrome P450-based cancer gene therapy: recent advances and future prospects

1 reference

12 December 2020

Resection of low-grade gliomas.

1 reference

12 December 2020

Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor.

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium

1 reference

12 December 2020

Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors

1 reference

12 December 2020

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

12 December 2020

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.

1 reference

12 December 2020

Myeloablative chemotherapy for recurrent aggressive oligodendroglioma

1 reference

12 December 2020

Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome

1 reference

12 December 2020

Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis

1 reference

12 December 2020

Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts

1 reference

12 December 2020

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

1 reference

12 December 2020

High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study.

1 reference

12 December 2020

Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation

1 reference

12 December 2020

High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study

1 reference

12 December 2020

Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7).

1 reference

12 December 2020

Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines

1 reference

12 December 2020

In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene

1 reference

12 December 2020

Biodegradable polymer implants to treat brain tumors

1 reference

12 December 2020

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.

1 reference

12 December 2020

Selective and rapid uptake of adeno-associated virus type 2 in brain

1 reference

12 December 2020

Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo

1 reference

12 December 2020

Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models

1 reference

12 December 2020

Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion

1 reference

12 December 2020

Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma

1 reference

12 December 2020

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

1 reference

12 December 2020

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

12 December 2020

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

1 reference

12 December 2020

Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.

1 reference

12 December 2020

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

1 reference

12 December 2020

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.

1 reference

12 December 2020

Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging

1 reference

12 December 2020

Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene.

1 reference

12 December 2020

The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial

1 reference

12 December 2020

Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival.

1 reference

12 December 2020

Distribution of AAV-TK following intracranial convection-enhanced delivery into rats.

1 reference

12 December 2020

Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model.

1 reference

12 December 2020

In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus

1 reference

12 December 2020

Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors

1 reference

12 December 2020

Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.

1 reference

12 December 2020

Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer

1 reference

12 December 2020

Comparison of 14C-sucrose delivery to the brain by intravenous, intraventricular, and convection-enhanced intracerebral infusion

1 reference

12 December 2020

Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma

1 reference

12 December 2020

Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase

1 reference

12 December 2020

The potential therapeutic gain of radiation-associated gene therapy with the suicide gene cytosine deaminase

1 reference

12 December 2020

Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption

1 reference

12 December 2020

Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain.

1 reference

12 December 2020

A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.

1 reference

12 December 2020

Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology

1 reference

12 December 2020

Protection of mammalian cells against chemotherapeutic agents thiotepa, 1,3-N,N'-bis(2-chloroethyl)-N-nitrosourea, and mafosfamide using the DNA base excision repair genes Fpg and alpha-hOgg1: implications for protective gene therapy applications.

1 reference

12 December 2020

Herpes simplex virus for gene delivery to neurons.

1 reference

12 December 2020

Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts

1 reference

12 December 2020

Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir

1 reference

12 December 2020

Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors

1 reference

12 December 2020

10.1007/S11910-002-0080-8

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1046883711

0 references

1 reference